We are live on
!
Find out more
PCA
Pallas Capital Advisors Portfolio holdings
AUM
$3.25B
1-Year Est. Return
40.07%
This Fund
S&P 500
This Quarter
Est. Return
-0.33%
1 Year Est. Return
+40.07%
3 Year Est. Return
+71.82%
5 Year Est. Return
+73.39%
10 Year Est. Return
–
AUM
$2.21B
AUM Growth
+$1.14B
(+107%)
Cap. Flow
+$1.14B
Cap. Flow
% of AUM
51.34%
Top 10 Holdings %
Top 10 Hldgs %
63.91%
Holding
304
New
35
Increased
125
Reduced
78
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bruker
BRKR
|
+$1.07B |
| 2 |
Vanguard Total Bond Market
BND
|
+$13.6M |
| 3 |
Dimensional International Value ETF
DFIV
|
+$9.86M |
| 4 |
Schwab International Equity ETF
SCHF
|
+$9.42M |
| 5 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$7.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$14.2M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.77M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$7.25M |
| 4 |
Medtronic
MDT
|
+$7.22M |
| 5 |
Goldman Sachs
GS
|
+$6.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.55% |
| 2 | Technology | 6.5% |
| 3 | Financials | 3.14% |
| 4 | Energy | 2.86% |
| 5 | Industrials | 2.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Viking Therapeutics
VKTX
$4B
| $208K | 0.01% |
+13,449
| New | +$282K |
|
252
FT Vest US Equity Buffer ETF October
FOCT
$1.19B
| $201K | 0.01% |
+5,250
| New | +$188K |
|
253
iShares ESG Advanced MSCI USA ETF
USXF
$1.49B
| $200K | 0.01% |
+5,428
| New | +$183K |
|
254
AT&T
T
$163B
| $187K | 0.01% |
13,849
+3,774
| +37% | +$64.3K |
|
255
Genworth Financial
GNW
$3.71B
| $85.5K | ﹤0.01% |
15,205
-1,000
| -6% | -$5.47K |
|
256
PAVmed
PAVM
$33.9M
| $18.8K | ﹤0.01% |
107
| – | – |
|
257
Nuvation Bio
NUVB
$2.32B
| $17.5K | ﹤0.01% |
10,284
+284
| +3% | +$483 |
|
258
Clene
CLNN
$67.5M
| $14.1K | ﹤0.01% |
867
| – | – |
|
259
American Financial Group
AFG
$12.1B
| – | – |
-11,594
| Closed | -$1.4M |
|
260
Allegion
ALLE
$14.4B
| – | – |
-12,839
| Closed | -$1.32M |
|
261
AMN Healthcare
AMN
$1.4B
| – | – |
-12,914
| Closed | -$1.14M |
|
262
Booz Allen Hamilton
BAH
$9.15B
| – | – |
-11,987
| Closed | -$1.16M |
|
263
Booking.com
BKNG
$161B
| – | – |
-1,900
| Closed | -$204K |
|
264
Blackrock
BLK
$176B
| – | – |
-362
| Closed | -$244K |
|
265
Church & Dwight Co
CHD
$24.5B
| – | – |
-9,282
| Closed | -$853K |
|
266
Chemed
CHE
$7.22B
| – | – |
-3,680
| Closed | -$2.09M |
|
267
Check Point Software Technologies
CHKP
$13.1B
| – | – |
-15,981
| Closed | -$2.09M |
|
268
C.H. Robinson
CHRW
$17.5B
| – | – |
-13,737
| Closed | -$1.35M |
|
269
Centene
CNC
$32.5B
| – | – |
-16,589
| Closed | -$1.12M |
|
270
Dollar General
DG
$27.9B
| – | – |
-14,598
| Closed | -$3.25M |
|
271
Dow Inc
DOW
$21.2B
| – | – |
-4,275
| Closed | -$237K |
|
272
Equifax
EFX
$21.4B
| – | – |
-4,997
| Closed | -$1M |
|
273
Eagle Materials
EXP
$6.57B
| – | – |
-10,900
| Closed | -$1.6M |
|
274
FTI Consulting
FCN
$4.18B
| – | – |
-6,400
| Closed | -$1.27M |
|
275
Globus Medical
GMED
$11.2B
| – | – |
-21,839
| Closed | -$1.27M |
|
Similar funds
AIP
BCI
EWA
SYBT
PCM
KIM
YCM
SC
Pallas Capital Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Pallas Capital Advisors held 304 positions worth $2.21B, up 107% from $1.07B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Pallas Capital Advisors deployed $1.14B of net new capital in Q2 2023, opening 35 new positions and adding to 125 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 ETF: 161,833 shares worth $8.58M.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $14.2M trimmed.
- Pallas Capital Advisors's largest Q2 2023 buy was State Street SPDR Portfolio S&P 500 ETF: 161,833 shares worth $8.58M.
- Pallas Capital Advisors added most to Bruker in Q2 2023, an estimated $1.07B increase.
- Pallas Capital Advisors's biggest Q2 2023 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $14.2M.
- Pallas Capital Advisors fully exited Northern Trust in Q2 2023, selling an estimated $5.22M.
- Pallas Capital Advisors's ten largest holdings make up 64% of its $2.21B portfolio in Q2 2023.
- Pallas Capital Advisors opened 35 new positions and closed 45 in Q2 2023.
- Pallas Capital Advisors's portfolio value rose 107% quarter-over-quarter to $2.21B.
Based on Pallas Capital Advisors's 13F filing for Q2 2023, filed 26 Jul 2023.